Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1820094
PUBLISHER: IMARC | PRODUCT CODE: 1820094
Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global epigenetics market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.02% during 2025-2033.
Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.
Epigenetics Market Trends:
The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
Breakup by Product:
- Reagents
- Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
- Instruments
- Enzymes
- Services
Breakup by Technology:
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large Non-Coding RNA
- MicroRNA Modification
- Chromatin Structures
Breakup by Application:
- Oncology
- Solid Tumors
- Liquid Tumors
- Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.
Key Questions Answered in This Report
- 1.How big is the global epigenetics market?
- 2.What is the expected growth rate of the global epigenetics market during 2025-2033?
- 3.What are the key factors driving the global epigenetics market?
- 4.What has been the impact of COVID-19 on the global epigenetics market?
- 5.What is the breakup of the global epigenetics market based on the product?
- 6.What is the breakup of the global epigenetics market based on the technology?
- 7.What is the breakup of the global epigenetics market based on the application?
- 8.What are the key regions in the global epigenetics market?
- 9.Who are the key players/companies in the global epigenetics market?
Product Code: SR112025A4096
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Epigenetics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Kits
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Chip Sequencing Kit
- 6.2.2.2 Whole Genomic Amplification Kit
- 6.2.2.3 Bisulfite Conversion Kit
- 6.2.2.4 RNA Sequencing Kit
- 6.2.2.5 Others
- 6.2.3 Market Forecast
- 6.3 Instruments
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Enzymes
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Services
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology
- 7.1 DNA Methylation
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Histone Methylation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Histone Acetylation
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Large Non-Coding RNA
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 MicroRNA Modification
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Chromatin Structures
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Key Segments
- 8.1.2.1 Solid Tumors
- 8.1.2.2 Liquid Tumors
- 8.1.3 Market Forecast
- 8.2 Non-Oncology
- 8.2.1 Market Trends
- 8.2.2 Key Segments
- 8.2.2.1 Inflammatory Diseases
- 8.2.2.2 Metabolic Diseases
- 8.2.2.3 Infectious Diseases
- 8.2.2.4 Cardiovascular Diseases
- 8.2.2.5 Others
- 8.2.3 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abcam plc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Active Motif Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Agilent Technologies Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Diagenode Diagnostics (Hologic Inc)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Illumina Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 PerkinElmer Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Roche Holding AG
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Thermo Fisher Scientific Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Zymo Research Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.1 Abcam plc
Product Code: SR112025A4096
List of Figures
- Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
- Figure 2: Global: Epigenetics Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2024
- Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2024
- Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2024
- Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2024
- Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: North America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: United States: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Canada: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: China: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Japan: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: India: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: South Korea: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Australia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Europe: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Germany: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: France: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Italy: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Spain: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Russia: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Latin America: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Brazil: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Mexico: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Others: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2024
- Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Global: Epigenetics Industry: SWOT Analysis
- Figure 84: Global: Epigenetics Industry: Value Chain Analysis
- Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Epigenetics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
- Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Epigenetics Market: Competitive Structure
- Table 7: Global: Epigenetics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.